SCHEMBL31201357

SCHEMBL31201357

CCC(CC)Nc1cc(NCCc2ccccn2)c2nnc(C3CC3)n2n1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ GABRG2 P18507 8/20 0.44
▸ GABRB3 P28472 8/20 0.44
▸ GABRA5 P31644 8/20 0.44
▸ GABRA3 P34903 8/20 0.44
▸ GABRA2 P47869 8/20 0.44
▸ GABRA1 P14867 7/20 0.44
▸ CYP1A2 P05177 1/20 0.37
▸ MKNK1 Q9BUB5 2/20 0.37
▸ OGA O60502 1/20 0.36
▸ CACNA2D1 P54289 1/20 0.35
▸ IGF1R P08069 1/20 0.35
▸ APP P05067 2/20 0.34
▸ HRH3 Q9Y5N1 1/20 0.34
▸ PKM P14618 1/20 0.34
▸ GSK3A P49840 1/20 0.34
▸ GSK3B P49841 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31201289 0.95 GABRA1 (0.42) GABRG2GABRB3GABRA5GABRA3GABRA2
SCHEMBL31201343 0.91 GABRG2 (0.46) GABRG2GABRB3GABRA5GABRA3GABRA2
SCHEMBL31201188 0.87 GABRA1 (0.45) GABRG2GABRB3GABRA5GABRA3GABRA2
SCHEMBL31201209 0.87 GABRA1 (0.47) GABRG2GABRB3GABRA5GABRA3GABRA2
SCHEMBL31201070 0.87 CACNA2D1 (0.41) GABRG2GABRB3GABRA5GABRA3GABRA2
SCHEMBL31201529 0.86 GABRA1 (0.44) GABRG2GABRB3GABRA5GABRA3GABRA2
SCHEMBL31201279 0.86 CDK2 (0.43) GABRG2GABRB3GABRA5GABRA3GABRA2
SCHEMBL31201241 0.86 CDK2 (0.43) GABRG2GABRB3GABRA5GABRA3GABRA2
SCHEMBL31201327 0.85 FLT3 (0.35) GABRG2GABRB3GABRA5GABRA3GABRA2
SCHEMBL31201336 0.84 GABRA1 (0.45) GABRG2GABRB3GABRA5GABRA3GABRA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4727944-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2026-04-22 — — EP claimed
WO-2024256496-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT PERHA PHARMACEUTICALS (FR) 2024-12-19 — — WO claimed
EP-4477653-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2024-12-18 — — EP claimed
EP-4727944-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2026-04-22 — — EP disclosed
WO-2024256496-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT PERHA PHARMACEUTICALS (FR) 2024-12-19 — — WO disclosed
EP-4477653-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2024-12-18 — — EP disclosed
Send feedback